Guodong He

2.1k total citations · 1 hit paper
55 papers, 1.3k citations indexed

About

Guodong He is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Guodong He has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 13 papers in Molecular Biology. Recurrent topics in Guodong He's work include Colorectal Cancer Surgical Treatments (13 papers), Ferroptosis and cancer prognosis (10 papers) and Colorectal and Anal Carcinomas (8 papers). Guodong He is often cited by papers focused on Colorectal Cancer Surgical Treatments (13 papers), Ferroptosis and cancer prognosis (10 papers) and Colorectal and Anal Carcinomas (8 papers). Guodong He collaborates with scholars based in China, United States and Hong Kong. Guodong He's co-authors include Jianmin Xu, Ye Wei, Meiling Ji, Qingyang Feng, Wenju Chang, Li Ren, Dexiang Zhu, Wentao Tang, Liangliang Yang and Yihao Mao and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Guodong He

52 papers receiving 1.3k citations

Hit Papers

Robotic versus laparoscopic surgery for middle and low re... 2022 2026 2023 2024 2022 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guodong He China 18 644 440 343 341 299 55 1.3k
Wenju Chang China 20 535 0.8× 403 0.9× 249 0.7× 313 0.9× 292 1.0× 79 1.3k
Ho Jung An South Korea 19 574 0.9× 278 0.6× 188 0.5× 201 0.6× 489 1.6× 90 1.2k
Takanori Ochiai Japan 20 469 0.7× 270 0.6× 212 0.6× 329 1.0× 215 0.7× 73 1.1k
Masaharu Ishida Japan 19 627 1.0× 414 0.9× 322 0.9× 623 1.8× 301 1.0× 91 1.4k
Xiao-Jun Wu China 18 625 1.0× 286 0.7× 169 0.5× 185 0.5× 118 0.4× 35 1.2k
Brenda Diergaarde United States 24 531 0.8× 577 1.3× 371 1.1× 192 0.6× 221 0.7× 68 1.5k
Muhammad S. Beg United States 13 264 0.4× 654 1.5× 535 1.6× 123 0.4× 143 0.5× 24 1.2k
Mojgan Asgari Iran 22 331 0.5× 471 1.1× 250 0.7× 178 0.5× 262 0.9× 61 1.0k
Radek Kučera Czechia 19 309 0.5× 281 0.6× 204 0.6× 94 0.3× 270 0.9× 94 1.0k

Countries citing papers authored by Guodong He

Since Specialization
Citations

This map shows the geographic impact of Guodong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guodong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guodong He more than expected).

Fields of papers citing papers by Guodong He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guodong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guodong He. The network helps show where Guodong He may publish in the future.

Co-authorship network of co-authors of Guodong He

This figure shows the co-authorship network connecting the top 25 collaborators of Guodong He. A scholar is included among the top collaborators of Guodong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guodong He. Guodong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Guodong, Weitang Yuan, Taiyuan Li, et al.. (2025). Influence of surgical start time on the quality of surgery for middle and low rectal cancer: a post hoc analysis of the real trial. International Journal of Surgery. 111(5). 3281–3288.
2.
Jiang, Chang, Qingyang Feng, Yihao Mao, et al.. (2024). Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer. International Immunopharmacology. 130. 111771–111771. 8 indexed citations
3.
He, Guodong, et al.. (2024). Task Scheduling Algorithm for Heterogeneous Computing Power Network. 1–5. 1 indexed citations
4.
Mai, Liping, et al.. (2024). Sex differences in the association between the muscle quality index and the incidence of depression: A cross-sectional study. World Journal of Psychiatry. 14(9). 1335–1345. 4 indexed citations
5.
Tang, Wentao, Yuqiu Xu, Wenju Chang, et al.. (2023). Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis. International Journal of Biological Sciences. 19(4). 1284–1298. 40 indexed citations
6.
Zhang, Zhiyuan, Meiling Ji, Qi Wu, et al.. (2021). Molecular Classification Based on Prognostic and Cell Cycle-Associated Genes in Patients With Colon Cancer. Frontiers in Oncology. 11. 636591–636591. 10 indexed citations
7.
Xu, Yuqiu, Qingyang Feng, Yijiao Chen, et al.. (2021). Significance of Surgery in the Treatment of Colorectal Cancer Ovarian Metastases: A Retrospective Case Matching Study. Cancer Management and Research. Volume 13. 1087–1097. 2 indexed citations
8.
Zhang, Zhiyuan, Meiling Ji, Yang Lv, et al.. (2020). A signature predicting relapse based on integrated analysis on relapse-associated alternative mRNA splicing in I–III rectal cancer. Genomics. 112(5). 3274–3283. 9 indexed citations
9.
Jian, Mi, Li Ren, Guodong He, et al.. (2020). A novel patient-derived organoids-based xenografts model for preclinical drug response testing in patients with colorectal liver metastases. Journal of Translational Medicine. 18(1). 234–234. 60 indexed citations
10.
Zhang, Zhiyuan, Qingyang Feng, Peng Zheng, et al.. (2020). Analysis of relapse-associated alternative mRNA splicing and construction of a prognostic signature predicting relapse in I–III colon cancer. Genomics. 112(6). 4032–4040. 12 indexed citations
11.
Zhang, Zhiyuan, Qi Wu, Dexiang Zhu, et al.. (2020). Tumor microenvironment derived signature predicting relapse-free survival in I-III cancer and preliminary experiment verification. International Immunopharmacology. 91. 107243–107243. 5 indexed citations
12.
Lv, Yang, Qingyang Feng, Ye Wei, et al.. (2020). Benefits of multi‐disciplinary treatment strategy on survival of patients with colorectal cancer liver metastasis. SHILAP Revista de lepidopterología. 10(3). e121–e121. 12 indexed citations
13.
Feng, Qingyang, Wenju Chang, Yihao Mao, et al.. (2019). Tumor-associated Macrophages as Prognostic and Predictive Biomarkers for Postoperative Adjuvant Chemotherapy in Patients with Stage II Colon Cancer. Clinical Cancer Research. 25(13). 3896–3907. 104 indexed citations
14.
Zhu, Hongcheng, et al.. (2019). Long intergenic noncoding RNA 00707 promotes colorectal cancer cell proliferation and metastasis by sponging miR-206. SHILAP Revista de lepidopterología. 1 indexed citations
15.
Hai, Bo, Yue Ma, Xiaoming Pan, et al.. (2019). Melatonin benefits to the growth of human annulus fibrosus cells through inhibiting miR-106a-5p/ATG7 signaling pathway. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Ji, Meiling, Wenxiang Li, Guodong He, et al.. (2019). Zinc-α2-glycoprotein 1 promotes EMT in colorectal cancer by filamin A mediated focal adhesion pathway. Journal of Cancer. 10(22). 5557–5566. 18 indexed citations
17.
Mao, Yihao, Qingyang Feng, Peng Zheng, et al.. (2018). Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer. Cancer Management and Research. Volume 10. 3569–3577. 87 indexed citations
18.
Zheng, Peng, Li Ren, Qingyang Feng, et al.. (2018). Differences in clinical characteristics and mutational pattern between synchronous and metachronous colorectal liver metastases. Cancer Management and Research. Volume 10. 2871–2881. 11 indexed citations
19.
Ji, Meiling, Guodong He, Liangliang Yang, et al.. (2017). Silencing CDR1as inhibits colorectal cancer progression through regulating microRNA-7. OncoTargets and Therapy. Volume 10. 2045–2056. 136 indexed citations
20.
Jiang, Yi, Guohao Wu, Guodong He, et al.. (2015). The Effect of Silencing HIF-1α Gene in BxPC-3 Cell Line on Glycolysis-Related Gene Expression, Cell Growth, Invasion, and Apoptosis. Nutrition and Cancer. 67(8). 1316–1325. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026